These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 10720058

  • 1. Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule.
    Sawai Y, DeGroot LJ.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1176-9. PubMed ID: 10720058
    [Abstract] [Full Text] [Related]

  • 2. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
    Pichurin P, Pham N, David CS, Rapoport B, McLachlan SM.
    Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
    [Abstract] [Full Text] [Related]

  • 3. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
    Inaba H, Martin W, De Groot AS, Qin S, De Groot LJ.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602
    [Abstract] [Full Text] [Related]

  • 4. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
    Degen H, Gavvovidis I, Blankenstein T, Uhland K, Ungerer M.
    Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
    [Abstract] [Full Text] [Related]

  • 5. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
    Li CW, Osman R, Menconi F, Concepcion E, Tomer Y.
    J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336
    [Abstract] [Full Text] [Related]

  • 6. Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves' disease.
    Kuang M, Wang S, Wu M, Ning G, Yao Z, Li L.
    Mol Cell Endocrinol; 2010 May 05; 319(1-2):23-9. PubMed ID: 20015465
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of glutamic or aspartic acid in position four of the epitope binding motif and thyrotropin receptor-extracellular domain epitope selection in Graves' disease.
    Inaba H, Martin W, Ardito M, De Groot AS, De Groot LJ.
    J Clin Endocrinol Metab; 2010 Jun 05; 95(6):2909-16. PubMed ID: 20392871
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
    Geluk A, Bloemhoff W, De Vries RR, Ottenhoff TH.
    Eur J Immunol; 1992 Jan 05; 22(1):107-13. PubMed ID: 1370411
    [Abstract] [Full Text] [Related]

  • 14. Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease.
    Cuddihy RM, Schaid DS, Bahn RS.
    Thyroid; 1996 Aug 05; 6(4):261-5. PubMed ID: 8875744
    [Abstract] [Full Text] [Related]

  • 15. Autoimmune T-cell recognition sites of human thyrotropin receptor in Graves' disease.
    Sakata S, Tanaka S, Okuda K, Miura K, Manshouri T, Atassi MZ.
    Mol Cell Endocrinol; 1993 Mar 05; 92(1):77-82. PubMed ID: 8472870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic Mice.
    Jansson L, Vrolix K, Jahraus A, Martin KF, Wraith DC.
    Endocrinology; 2018 Sep 01; 159(9):3446-3457. PubMed ID: 30099489
    [Abstract] [Full Text] [Related]

  • 19. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T, Moriyama K, Miura M, Saijo M, Matsuda F, Nakao K.
    Endocrinology; 1999 Apr 01; 140(4):1594-601. PubMed ID: 10098493
    [Abstract] [Full Text] [Related]

  • 20. Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries.
    Park JY, Kim IJ, Lee MH, Seo JK, Suh PG, Cho BY, Ryu SH, Chae CB.
    Endocrinology; 1997 Feb 01; 138(2):617-26. PubMed ID: 9002995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.